Cacoub, Patrice
Nicolas, Gael
Peoc’h, Katell
Funding for this research was provided by:
Vifor France
Article History
Received: 6 May 2020
Accepted: 24 June 2020
First Online: 11 September 2020
Competing interests
: Patrice Cacoub has received consulting and lecturing fees from Abbvie, AstraZeneca, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Servier, and Vifor. Katell Peoc'h has received consulting and lecturing fees from France, Fresenius, Kabi, Masimo, Octapharma, Werfen, Vifor, Siemens Healthineers, Abbott, Brahms, Diasorin and research grants from MSD Avenir and Fujirebio. Gaël Nicolas has declare no competing interest.